Molecular Diagnostic Market is rising in UAE
The 2019 Molecular Medicine Conference is bringing together 50+ professionals from 9+ countries for education, innovation, and collaboration. Choose from 20+ education sessions, many of special sessions and endless networking events.
- (1888PressRelease) March 12, 2019 - The growth of the UAE diagnostic market can be attributed to the high prevalence of chronic and infectious diseases. WHO estimates of all deaths worldwide, Chronic diseases account for approximately 60 %. Chronic diseases such as cancer, cardiovascular diseases, diabetes, and chronic respiratory diseases are responsible for 12%, 40%, 5%, and 5% of mortality in the United Arab Emirates. There has been a paradigm shift from traditional diagnostics to a new generation diagnostic, that works at the gene level. The inclusion of Advanced technologies such as genetic testing, molecular diagnostics, polymerase chain reaction (PCR), and next-generation sequencing (NGS) made it possible.
The major market players in the UAE molecular diagnostics market are :
• BioMérieux
• Qiagen
• Abbott Laboratories
• Roche Diagnostics and
• Siemens among others
The competition among manufacturers is increasing, with the increasing number of companies.
ME Conferences is pleased to announce the upcoming “4th International Conference on Molecular Medicine and Diagnostics” during July 15-16, 2019 in Abu Dhabi, UAE. Molecular Medicine 2019 focuses on sharing of scientific knowledge and experience in all areas applied to Molecular Medicine, Diagnostics and related scientific fields. It provides the platform for researchers, scientists, and educators to present and discuss the most recent innovations, trends, concerns, practical challenges encountered, and solutions adopted in the fields of Molecular Medicine and Diagnostics. This conference is oriented to shape future research directions by driving the scientific community at large by facilitating access to the newest technical and scientific achievements. Abstracts are welcome in all areas related to Molecular Medicine and Diagnostics.
Molecular Medicine 2019 has been accredited by the Continuing Professional Development (CPD). Continuing professional development is important because it ensures you continue to be competent in your profession. It is an ongoing process and continues throughout a professional's career. The certificate will indicate that you are up to date with renovated knowledge in recent research in your field.
###
space
space
Satisfied Users & 
Approved Press Releases
Print
Email
Report Spam